20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Privia Health Group Inc (PRVA) operates in the HEALTH INFORMATION SERVICES industry and is headquartered in Arlington, United States with about 1,226 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, PRVA reported $2.1B in revenue and $23M in net income.
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems.
Interactive charts & full statements → Open the PRVA valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.4B | $2.1B | $1.7B | $1.7B | $1.4B | $966M | $817M | $786M | $658M |
| Gross Profit | $179M | $209M | $177M | $162M | $135M | $64M | $83M | $68M | $56M |
| Gross Margin % | 7.6% | 9.9% | 10.2% | 9.7% | 9.9% | 6.6% | 10.1% | 8.7% | 8.6% |
| Operating Income (EBIT) | $45M | $34M | $17M | $21M | ($19M) | ($217M) | $25M | $16M | $2M |
| Operating Margin % | 1.9% | 1.6% | 1.0% | 1.2% | -1.4% | -22.5% | 3.1% | 2.0% | 0.3% |
| Net Income | $28M | $23M | $14M | $23M | ($9M) | ($188M) | $31M | $8M | ($3M) |
| Net Margin % | 1.2% | 1.1% | 0.8% | 1.4% | -0.6% | -19.5% | 3.8% | 1.1% | -0.5% |
| EBITDA | $68M | $54M | $35M | $36M | ($14M) | ($215M) | $27M | $17M | $3M |
| Earnings Per Share (EPS) | $0.22 | $0.18 | $0.11 | $0.19 | $-0.08 | $-1.75 | $0.30 | $0.08 | $-0.03 |
| Shares Outstanding (M) | 132M | 129M | 126M | 125M | 111M | 108M | 106M | 106M | 103M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $633M | $604M | $541M | $580M | $521M | $480M | $461M | $438M |
| Gross Profit | $12M | $57M | $50M | $61M | $48M | $46M | $48M | $45M |
| Gross Margin % | 1.9% | 9.4% | 9.2% | 10.5% | 9.2% | 9.5% | 10.4% | 10.4% |
| Operating Income (EBIT) | $12M | $7M | $11M | $14M | $3M | $5M | $5M | $6M |
| Operating Margin % | 1.9% | 1.2% | 2.1% | 2.5% | 0.6% | 1.1% | 1.1% | 1.3% |
| Net Income | $9M | $3M | $9M | $7M | $3M | $4M | $4M | $4M |
| Net Margin % | 1.4% | 0.5% | 1.7% | 1.2% | 0.5% | 0.9% | 0.9% | 0.8% |
| EBITDA | $20M | $13M | $16M | $19M | $8M | $10M | $10M | $10M |
| Earnings Per Share (EPS) | $0.07 | $0.02 | $0.07 | $0.05 | $0.02 | $0.03 | $0.03 | $0.03 |
| Shares Outstanding (M) | 132M | 131M | 130M | 129M | 128M | 128M | 126M | 126M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($47M) | $163M | $109M | $81M | $47M | $55M | $39M | $24M | $5M |
| Capital Expenditures (CapEx) | $2M | $1M | $5M | $0M | $0M | $1M | $0M | $6M | $0M |
| Free Cash Flow (FCF) | ($49M) | $162M | $104M | $81M | $47M | $55M | $39M | $19M | $5M |
| FCF Margin % | -2.1% | 7.6% | 6.0% | 4.9% | 3.5% | 5.6% | 4.7% | 2.4% | 0.8% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($177M) | ($49M) | $128M | $52M | $8M | ($24M) | $75M | $33M |
| Capital Expenditures (CapEx) | $0M | $0M | $1M | $1M | $0M | $0M | $0M | $5M |
| Free Cash Flow (FCF) | ($177M) | ($49M) | $126M | $51M | $8M | ($24M) | $75M | $28M |
| FCF Margin % | -28.0% | -8.2% | 23.3% | 8.8% | 1.5% | -5.0% | 16.2% | 6.4% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.49T | $1.4B | $1.1B | $1.0B | $793M | $686M | $329M | $270M | $249M |
| Cash & Cash Equivalents | $412.2B | $480M | $491M | $390M | $348M | $321M | $85M | $47M | $39M |
| Total Liabilities | $650.5B | $578M | $452M | $393M | $274M | $236M | $185M | $163M | $163M |
| Total Debt (Short + Long-Term) | $2.1B | $2M | $3M | $3M | $3M | $35M | $34M | $43M | $7M |
| Total Shareholders' Equity | $782.3B | $737M | $635M | $561M | $499M | $427M | $147M | $110M | $88M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PRVA viewer.
About TickerBase · Data methodology & sources · Privacy · Terms